Parexel

July is Disability Pride Month, and we’re celebrating the contributions and experiences of individuals in the disability community. 🌈 To this end and as part of our commitment to inclusive clinical research, we launched our inaugural Ophthalmology Patient Advisory Councils to better understand and improve the accessibility of trials for patients in the Ophthalmology community.   Recent meetings focused on inherited retinal diseases and Usher Syndrome, with insightful discussions on the importance of:   🔸 Raising awareness of clinical trials for patients with blinding diseases, the vital role care partners play and the support services needed to facilitate participation in trials.   🔸 Using communication aids to increase healthcare accessibility for the Usher Syndrome community and exploration of better ways to communicate consent in clinical research.   A huge thank you to Foundation Fighting Blindness — one of our 2024 Corporate Patient Advocacy Partners — for working closely with Parexel to connect with patients and care partners who provide invaluable personal insights to our councils. 🩺 🌍

📣 We're thrilled to announce our "Next Generation" Site Scholarship program, exclusively for emerging investigative sites! The scholarships will provide support and resources to help emerging sites ─ the next generation of clinical research ─ reach the next level. 🚀 Each of our 10 scholarship recipients will receive 🔹 A one-year SCRS membership with online training 🔹 Mentoring sessions with experienced sites in our Site Alliance Program 🔹 A dedicated Parexel Site Alliance Manager 🔹 One complimentary pass to the 2024 SCRS Global Site Solutions Summit. Don't miss this opportunity to accelerate your site's success! Apply today: https://lnkd.in/e_bpyVnx

At Parexel, we understand that embracing diversity, equity and inclusion (DEI) is not just the right thing to do — it's essential to driving innovation and serving our global community effectively. 🌍✨ Through employee-led committees, Patient Advisory Councils, robust DEI training and a diverse workforce that reflects the patients we serve, we're setting standards across our industry. By fostering an environment where unique perspectives thrive, we're not just improving outcomes for patients—we're also creating a workplace where everyone can succeed and contribute to our mission. Learn how we're integrating DEI in everything we do at Parexel: https://insde.co/g7g0

We strive to design and deliver clinical trials with patients in mind, making clinical research a care option for anyone, anywhere. By tapping into real-world patient insights, we’re able to include diverse patients, design trials that meet their needs, and yield effective drugs that work across populations. We are excited to announce that Chief Patient Officer Stacy Hurt 🌻 will lead our on-site team at the #CPOSummit in Boston! Stacy will present with patient advocacy leaders on the latest approaches to improving trial experiences and the meaningful benefits this commitment offers both patients and drug developers. Drop a comment below about what you are looking forward to hearing about 👇 Schedule a meeting with our team at the event or learn more about our participation here: https://lnkd.in/dvvQ9PSs #PatientsFirst #PatientAdvocacy #PatientInsights #ClinicalTrials

Tune in to Episode 2 of ACRO's Good Clinical Podcast, where Stephen Pyke and the FDA's Dr. Tala Fakhouri discuss the massive potential of AI in clinical research. 🎙   Learn more about the FDA's evidentiary standards for AI, the importance of methodological transparency in submissions and how AI stands to streamline the drug development process, helping to bring life-changing medicines to market more efficiently. 💡 Stephen also sheds light on where AI advancements will show up and what it means for patients. 👇 Watch below! Don’t miss this fascinating discussion. Access the full episode here: https://lnkd.in/gdMz_agR #ACRO #GoodClinicalPodcast #ArtificialIntelligence 

Accelerating clinical trials takes on special urgency in oncology. Martin Roessner explains how Parexel Biotech is advancing innovative approaches to optimize study design and streamline protocols. He shares that the more flexible the study, the more complex it is. However, even in the case of a biotech company with limited capital, a flexible trial design could confirm efficacy and safety as an early milestone and potentially lead to a second round of financing. Read the full article and be sure to follow the rest of this oncology blog series: https://lnkd.in/gRPwG6EE Learn more about how our dedicated team of Biotech experts will amplify your team's expertise to help you uncover insights faster. #ClinicalResearch #Biotech #Innovation #Oncology #ParexelBiotech

The analysis of large published literature to gather safety and efficacy information on medical products is critical for compliance and patient safety. This week, we spoke with Pallavi Rehal, Director of Pharmacovigilance Operations at Parexel, about how #AI is supporting her team’s efforts in safety services.    Click through to read her opinions on artificial intelligence in clinical research in the latest edition of our #AIandMe series. Share your experiences below!   #Pharmacovigilance #ArtificialIntelligence #MachineLearning #DrugSafety 

Chief Patient Officer Stacy Hurt 🌻joined Alicia C. Staley of Medidata Solutions to kick off Season 2 of ACRO's Good Clinical Podcast with Sophia McLeod! 🎧   Tune in to hear how Stacy’s experiences as a patient and caregiver have shaped her perspective on the vital role of the patient voice in reducing burden and turning buzz words into action! 💪  https://lnkd.in/gdMz_agR

Are biomarkers the key to diagnosing and treating cancer effectively? 🔑 They help identify patients who will benefit most from targeted therapies, making clinical trials faster and more efficient. However, reliable biomarkers are still lacking for many cancers. 🔎 At Parexel, our team of experts is leveraging diverse data streams and exciting advances in #AI and #machinelearning to fast-track cancer research and improve patient outcomes. We asked Angela Qu to describe how recent advances in multi-omics and computational analytics accelerate the discovery and validation of biomarkers in precision oncology. Read her responses here: https://lnkd.in/g2RPNWNS #Biomarkers #Oncology #PrecisionOncology #NovelInsights

Over the past three years, Parexel and Veeva Systems have collaborated to accelerate clinical trials through Veeva’s suite of technology applications, including Veeva Vault eTMF, Vault CTMS, Veeva EDC and Vault Study Startup. Together we've streamlined trial processes, created efficiencies and made clinical trial participation easier for all. 💪   Parexel colleagues connected recently with the Veeva team to discuss ways to further enhance the clinical trials experience for participants, patients and site professionals. Exciting times ahead as we continue to innovate and transform clinical research! #Veeva #ClinicalTrials #Collaboration